Drug product formulations exert a crucial role in determining the magnitude of drug bioavailability. Bioavailability refers to the proportion of an administered dose that arrives the systemic circulation in an active form. Optimizing formulations can significantly improve this process, leading to more effective drug delivery and therapeutic outcome

Eli Lilly and Company has emerged as in the production of tirzepatide, a groundbreaking drug for type 2 diabetes. Tirzepatide, a dual GIP and GLP-1 receptor agonist, demonstrates significant ability to improve glycemic control and reduce heart disease. The complex manufacturing process of tirzepatide utilizes a series of meticulous processes to ens